Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP296563.RAl5b--raRCjdjrrpbFeDdBK_0ck9ez7vIKztGiGLIF9Q130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP296563.RAl5b--raRCjdjrrpbFeDdBK_0ck9ez7vIKztGiGLIF9Q130_assertion type Assertion NP296563.RAl5b--raRCjdjrrpbFeDdBK_0ck9ez7vIKztGiGLIF9Q130_head.
- NP296563.RAl5b--raRCjdjrrpbFeDdBK_0ck9ez7vIKztGiGLIF9Q130_assertion description "[Moreover, of the patients with advanced urothelial carcinoma who underwent complete resection disease-free survival of those with an elevated CD44v8-10- to -standard CD44 ratio was significantly lower than that of patients with a normal ratio.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP296563.RAl5b--raRCjdjrrpbFeDdBK_0ck9ez7vIKztGiGLIF9Q130_provenance.
- NP296563.RAl5b--raRCjdjrrpbFeDdBK_0ck9ez7vIKztGiGLIF9Q130_assertion evidence source_evidence_literature NP296563.RAl5b--raRCjdjrrpbFeDdBK_0ck9ez7vIKztGiGLIF9Q130_provenance.
- NP296563.RAl5b--raRCjdjrrpbFeDdBK_0ck9ez7vIKztGiGLIF9Q130_assertion SIO_000772 11832714 NP296563.RAl5b--raRCjdjrrpbFeDdBK_0ck9ez7vIKztGiGLIF9Q130_provenance.
- NP296563.RAl5b--raRCjdjrrpbFeDdBK_0ck9ez7vIKztGiGLIF9Q130_assertion wasDerivedFrom befree-20150227 NP296563.RAl5b--raRCjdjrrpbFeDdBK_0ck9ez7vIKztGiGLIF9Q130_provenance.
- NP296563.RAl5b--raRCjdjrrpbFeDdBK_0ck9ez7vIKztGiGLIF9Q130_assertion wasGeneratedBy ECO_0000203 NP296563.RAl5b--raRCjdjrrpbFeDdBK_0ck9ez7vIKztGiGLIF9Q130_provenance.